JPS6355353B2 - - Google Patents

Info

Publication number

JPS6355353B2

JPS6355353B2 JP58247426A JP24742683A JPS6355353B2 JP S6355353 B2 JPS6355353 B2 JP S6355353B2 JP 58247426 A JP58247426 A JP 58247426A JP 24742683 A JP24742683 A JP 24742683A JP S6355353 B2 JPS6355353 B2 JP S6355353B2

Authority

JP

Japan

Prior art keywords

blood

plasma

separator

membrane

line

Prior art date

1983-12-26

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired

Links

• Espacenet
• Global Dossier
• Discuss

• 210000004369 blood Anatomy 0.000 claims description 111
• 239000008280 blood Substances 0.000 claims description 111
• 239000012528 membrane Substances 0.000 claims description 36
• 239000003146 anticoagulant agent Substances 0.000 claims description 14
• 229940127219 anticoagulant drug Drugs 0.000 claims description 14
• 210000003462 vein Anatomy 0.000 claims description 13
• 238000011144 upstream manufacturing Methods 0.000 claims description 11
• 238000000926 separation method Methods 0.000 claims description 10
• 230000036770 blood supply Effects 0.000 claims description 3
• 239000002504 physiological saline solution Substances 0.000 description 5
• BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 4
• 238000000034 method Methods 0.000 description 4
• 238000001802 infusion Methods 0.000 description 3
• 239000000463 material Substances 0.000 description 3
• 206010018910 Haemolysis Diseases 0.000 description 2
• 230000017531 blood circulation Effects 0.000 description 2
• 230000004087 circulation Effects 0.000 description 2
• 238000010586 diagram Methods 0.000 description 2
• 230000008588 hemolysis Effects 0.000 description 2
• -1 polyethylene Polymers 0.000 description 2
• BQCIDUSAKPWEOX-UHFFFAOYSA-N 1,1-Difluoroethene Chemical compound FC(F)=C BQCIDUSAKPWEOX-UHFFFAOYSA-N 0.000 description 1
• 229920001747 Cellulose diacetate Polymers 0.000 description 1
• 229920002284 Cellulose triacetate Polymers 0.000 description 1
• 239000004698 Polyethylene Substances 0.000 description 1
• NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
• 239000010836 blood and blood product Substances 0.000 description 1
• 210000000601 blood cell Anatomy 0.000 description 1
• 230000036772 blood pressure Effects 0.000 description 1
• 229940125691 blood product Drugs 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 239000000701 coagulant Substances 0.000 description 1
• 230000001112 coagulating effect Effects 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 230000000694 effects Effects 0.000 description 1
• 239000005038 ethylene vinyl acetate Substances 0.000 description 1
• 239000012510 hollow fiber Substances 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 229920002239 polyacrylonitrile Polymers 0.000 description 1
• 229920000573 polyethylene Polymers 0.000 description 1
• 229920005672 polyolefin resin Polymers 0.000 description 1
• 238000004062 sedimentation Methods 0.000 description 1
• 239000000243 solution Substances 0.000 description 1